These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18608751)

  • 1. A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice.
    Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K
    J Enzyme Inhib Med Chem; 2008 Dec; 23(6):776-80. PubMed ID: 18608751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Jung YS
    Drug Chem Toxicol; 2008; 31(3):371-81. PubMed ID: 18622871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J; Kuca K; Cabal J; Paar M
    J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Kuca K; Musilek K
    Drug Chem Toxicol; 2010 Jul; 33(3):227-32. PubMed ID: 20429807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Musilek K; Horova A
    Toxicol Mech Methods; 2013 Feb; 23(2):94-8. PubMed ID: 22901042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Musilek K; Horova A
    Toxicol Mech Methods; 2014 Mar; 24(3):173-8. PubMed ID: 24295433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
    J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.
    Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J; Sepsova V; Caisberger F; Pejchal J
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28696367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the potency of trimedoxime and other currently available oximes to reactivate tabun-inhibited acetylcholinesterase and eliminate acute toxic effects of tabun.
    Kassa J; Kuca K; Cabal J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):419-23. PubMed ID: 16601802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
    Kassa J; Jun D; Karasova J; Bajgar J; Kuca K
    Chem Biol Interact; 2008 Sep; 175(1-3):425-7. PubMed ID: 18547554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Bajgar J
    Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
    J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun.
    Kassa J; Kuca K; Karasova J; Musilek K
    Mini Rev Med Chem; 2008 Oct; 8(11):1134-43. PubMed ID: 18855728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.